Dezhan Healthcare Company Limited (SHE:000813)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Industry	394.03M	463.89M	489.24M	562.19M	703.17M
Pharmaceutical Industry Growth	-15.06%	-5.18%	-12.98%	-20.05%	-26.66%
Peptides	1.77M	2.09M	5.88M	4.85M	7.09M
Peptides Growth	-15.34%	-64.38%	21.17%	-31.62%	575.64%
Other	1.01M	498.15K	699.69K	234.98K	33.48K
Other Growth	102.00%	-28.80%	197.77%	601.91%	-33.69%
Industrial Hemp	-	-	2.27M	3.58M	24.19M
Industrial Hemp Growth	-	-	-36.59%	-85.20%	711.12%
Total	396.81M	466.49M	498.09M	570.86M	734.48M
Total Growth	-14.94%	-6.34%	-12.75%	-22.28%	-23.72%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	396.43M	466.49M	497.43M	570.42M	733.45M
China Growth	-15.02%	-6.22%	-12.80%	-22.23%	-23.78%
Overseas	381.25K	-	660.96K	432.51K	1.03M
Overseas Growth	-	-	52.82%	-57.86%	81.20%
Total	396.81M	466.49M	498.09M	570.86M	734.48M
Total Growth	-14.94%	-6.34%	-12.75%	-22.28%	-23.72%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error